Roberta La Starza Selected Research

Nucleotides

1/2020

New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberta La Starza Research Topics

Disease

9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2002
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2013 - 05/2002
8	Neoplasms (Cancer) 02/2022 - 08/2002
6	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022 - 07/2015
5	Leukemia 01/2020 - 10/2002
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2015 - 02/2002
3	Lymphoma (Lymphomas) 01/2022 - 01/2020
3	Hypereosinophilic Syndrome (Loeffler Endocarditis) 05/2005 - 04/2004
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 08/2002
2	Pdgfra-Associated Chronic Eosinophilic Leukemia 02/2008 - 05/2005
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 03/2007 - 10/2005
1	Eosinophilia 02/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Residual Neoplasm 01/2020
1	Hemoglobinopathies 01/2020
1	Lymphoid Leukemia 07/2015
1	Malignant Mesothelioma 03/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2015
1	Gliosarcoma 03/2015
1	Cataract (Cataracts) 01/2013
1	hereditary Hyperferritinemia with congenital cataracts 01/2013
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 10/2009
1	Acute Myelomonocytic Leukemia 10/2007
1	Refractory Anemia 12/2004
1	Primitive Neuroectodermal Tumors (PNET) 10/2002
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2002
1	Carcinogenesis 10/2002

Drug/Important Bio-Agent (IBA)

8	nuclear pore complex protein 98IBA 07/2015 - 05/2002
4	Phosphotransferases (Kinase)IBA 01/2020 - 08/2002
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2022 - 02/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
3	Imatinib Mesylate (Gleevec)FDA Link 10/2009 - 04/2004
3	Tyrosine (L-Tyrosine)FDA Link 03/2007 - 08/2002
1	Glycogen Synthase (Synthase I)IBA 06/2022
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022
1	daratumumabIBA 01/2022
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2020
1	CytokinesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 01/2020
1	NucleotidesIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	venetoclaxIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	MTOR InhibitorsIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Janus Kinase InhibitorsIBA 10/2015
1	AsbestosIBA 03/2015
1	Protein Isoforms (Isoforms)IBA 03/2013
1	IronIBA 01/2013
1	ApoferritinsIBA 01/2013
1	Topoisomerase II InhibitorsIBA 10/2007
1	VimentinIBA 01/2007
1	NestinIBA 01/2007
1	Janus Kinase 2IBA 01/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2006
1	HeterochromatinIBA 10/2005
1	Genetic Markers (Genetic Marker)IBA 05/2005
1	NucleophosminIBA 01/2005
1	Contrast MediaIBA 12/2004
1	contrast agent BR1IBA 12/2004
1	Transcription Factors (Transcription Factor)IBA 10/2002
1	Dacarbazine (DIC)FDA LinkGeneric 02/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2007
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
1	Induction Chemotherapy 01/2020
1	Transplantation 06/2008